-
1
-
-
0033549287
-
Clozapine in drug-induced psychosis in Parkinson's disease
-
The French Clozapine Parkinson Study Group
-
The French Clozapine Parkinson Study Group. Clozapine in drug-induced psychosis in Parkinson's disease. Lancet 1999;353:2041-2042.
-
(1999)
Lancet
, vol.353
, pp. 2041-2042
-
-
-
3
-
-
0035241276
-
Clozapine for the treatment of drug-induced psychosis in Parkinson's disease: Results of the 12 week open label extension in the PSYCLOPS trial
-
Factor SA, Friedman JH, Lannon MC et al. Clozapine for the treatment of drug-induced psychosis in Parkinson's disease: results of the 12 week open label extension in the PSYCLOPS trial. Mov Disord 2001;16:135-139.
-
(2001)
Mov. Disord.
, vol.16
, pp. 135-139
-
-
Factor, S.A.1
Friedman, J.H.2
Lannon, M.C.3
-
4
-
-
0030819935
-
The emerging role of clozapine in the treatment of movement disorders
-
Factor SA, Friedman JH. The emerging role of clozapine in the treatment of movement disorders. Mov Disord 1997;12:483-496.
-
(1997)
Mov. Disord.
, vol.12
, pp. 483-496
-
-
Factor, S.A.1
Friedman, J.H.2
-
6
-
-
0003984765
-
-
55th Edition. Montvale, NJ: Medical Economics Company
-
Physician's Desk Reference. 55th Edition. Montvale, NJ: Medical Economics Company; 2001. p 2155-2159.
-
(2001)
Physician's Desk Reference
, pp. 2155-2159
-
-
-
7
-
-
0034758931
-
Neuroleptic malignant syndrome associated with long-term clozapine treatment: Report of a case and results of a clozapine rechallenge
-
Huang TL. Neuroleptic malignant syndrome associated with long-term clozapine treatment: report of a case and results of a clozapine rechallenge. Chang Gung Med J 2001;24:522-525.
-
(2001)
Chang Gung Med. J.
, vol.24
, pp. 522-525
-
-
Huang, T.L.1
-
8
-
-
0031934775
-
Neuroleptic malignant syndrome related to use of clozapine
-
Trayer JS, Fidler DC. Neuroleptic malignant syndrome related to use of clozapine. J Am Osteopath Assoc 1998;98:168-169.
-
(1998)
J. Am. Osteopath. Assoc.
, vol.98
, pp. 168-169
-
-
Trayer, J.S.1
Fidler, D.C.2
-
10
-
-
0029119464
-
Clinical implications of clozapine discontinuation: Report of an NIMH workshop
-
Clinical implications of clozapine discontinuation: report of an NIMH workshop. Schizophr Bull 1995;21:333-338.
-
(1995)
Schizophr. Bull.
, vol.21
, pp. 333-338
-
-
-
11
-
-
0032842391
-
Controlled, double-blind investigation of the clozapine discontinuation symptoms with conversion to either olanzapine or placebo
-
Tollefson GD, Dellva MA, Mattler CA, et al. Controlled, double-blind investigation of the clozapine discontinuation symptoms with conversion to either olanzapine or placebo. J Clin Psychopharmacol 1999;19:435-443.
-
(1999)
J. Clin. Psychopharmacol.
, vol.19
, pp. 435-443
-
-
Tollefson, G.D.1
Dellva, M.A.2
Mattler, C.A.3
-
12
-
-
0029958232
-
Cholinergic rebound and rapid onset psychosis following abrupt clozapine withdrawal
-
Shiovitz TM, Welke TL, Tigel PD, et al. Cholinergic rebound and rapid onset psychosis following abrupt clozapine withdrawal. Schizophr Bull 1996;22:591-595.
-
(1996)
Schizophr. Bull.
, vol.22
, pp. 591-595
-
-
Shiovitz, T.M.1
Welke, T.L.2
Tigel, P.D.3
-
14
-
-
0030789315
-
Clozapine withdrawal resulting in delirium with psychosis: A report of three cases
-
Stanilla JK, de Leon J, Simpson GM. Clozapine withdrawal resulting in delirium with psychosis: a report of three cases. J Clin Psychiatry 1997;58:252-255.
-
(1997)
J. Clin. Psychiatry
, vol.58
, pp. 252-255
-
-
Stanilla, J.K.1
de Leon, J.2
Simpson, G.M.3
-
15
-
-
0031686299
-
Clozapine withdrawal-emergent dystonias and dyskinesias: A case series
-
Ahmed S, Chengappa R, Naidu VR, et al. Clozapine withdrawal-emergent dystonias and dyskinesias: a case series. J Clin Psychiatry 1998;59:472-477.
-
(1998)
J. Clin. Psychiatry
, vol.59
, pp. 472-477
-
-
Ahmed, S.1
Chengappa, R.2
Naidu, V.R.3
-
16
-
-
0029916129
-
Relapse following clozapine withdrawal: Effect of cyproheptadine plus neuroleptic
-
Meltzer HY, Lee MA, Ranjan R, et al. Relapse following clozapine withdrawal: effect of cyproheptadine plus neuroleptic. Psychopharmacology 1996;124:176-187.
-
(1996)
Psychopharmacology
, vol.124
, pp. 176-187
-
-
Meltzer, H.Y.1
Lee, M.A.2
Ranjan, R.3
-
19
-
-
0030762018
-
Clozapine withdrawal: Serotonergic or dopaminergic mechanisms?
-
Meltzer HY. Clozapine withdrawal: serotonergic or dopaminergic mechanisms? Arch Gen Psychiatry 1997;54:760-763.
-
(1997)
Arch. Gen. Psychiatry
, vol.54
, pp. 760-763
-
-
Meltzer, H.Y.1
-
20
-
-
0021259918
-
Supersensitivity psychosis in schizophrenic patients after sudden clozapine withdrawal
-
Ekbom T, Eriksson K, Lindstrom LH. Supersensitivity psychosis in schizophrenic patients after sudden clozapine withdrawal. Psychopharmacology 1984;83:293-294.
-
(1984)
Psychopharmacology
, vol.83
, pp. 293-294
-
-
Ekbom, T.1
Eriksson, K.2
Lindstrom, L.H.3
-
21
-
-
0021798337
-
Early relapse after sudden withdrawal or dose reduction of clozapine
-
Perenyi A, Kuncz E, Bagdy G. Early relapse after sudden withdrawal or dose reduction of clozapine. Psychopharmacology 1986;86:244.
-
(1986)
Psychopharmacology
, vol.86
, pp. 244
-
-
Perenyi, A.1
Kuncz, E.2
Bagdy, G.3
-
22
-
-
0023143938
-
Supersensitivity and clozapine withdrawal
-
Eklund K. Supersensitivity and clozapine withdrawal. Psychopharmacology 1987;90:135.
-
(1987)
Psychopharmacology
, vol.90
, pp. 135
-
-
Eklund, K.1
-
23
-
-
0026072731
-
Comparison of withdrawal of typical and atypical antipsychotic drugs: A case study
-
Alphs LK,Lee HS. Comparison of withdrawal of typical and atypical antipsychotic drugs: a case study. J Clin Psychiatry 1991;52: 346-348.
-
(1991)
J. Clin. Psychiatry
, vol.52
, pp. 346-348
-
-
Alphs, L.K.1
Lee, H.S.2
-
25
-
-
0031919315
-
Clozapine use in Parkinson's disease: A retrospective analysis of a large multicentered clinical experience
-
Trosch RM, Friedman JH, Lannon MC, et al. Clozapine use in Parkinson's disease: a retrospective analysis of a large multicentered clinical experience. Mov Disord 1998;13:377-382.
-
(1998)
Mov. Disord.
, vol.13
, pp. 377-382
-
-
Trosch, R.M.1
Friedman, J.H.2
Lannon, M.C.3
-
26
-
-
0033453264
-
Quetiapine for the treatment of drug-induced psychosis in Parkinson's disease
-
Fernandez HH, Friedman JH, Jacques C, Rosenfeld M. Quetiapine for the treatment of drug-induced psychosis in Parkinson's disease. Mov Disord 1999;14:484-487.
-
(1999)
Mov. Disord.
, vol.14
, pp. 484-487
-
-
Fernandez, H.H.1
Friedman, J.H.2
Jacques, C.3
Rosenfeld, M.4
-
27
-
-
0034074975
-
Clozapine replacement by Quetiapine for the treatment of drug-induced psychosis in Parkinson's disease
-
Fernandez HH, Lannon MC, Friedman JH, Abbot BP. Clozapine replacement by Quetiapine for the treatment of drug-induced psychosis in Parkinson's disease. Mov Disord 2000;15:579-581.
-
(2000)
Mov. Disord.
, vol.15
, pp. 579-581
-
-
Fernandez, H.H.1
Lannon, M.C.2
Friedman, J.H.3
Abbot, B.P.4
-
28
-
-
0016168437
-
Clozapine: A new antipsychotic agent
-
Simpson GM, Varga E. Clozapine: A new antipsychotic agent. Curr Ther Res 1974;16:679-686.
-
(1974)
Curr. Ther. Res.
, vol.16
, pp. 679-686
-
-
Simpson, G.M.1
Varga, E.2
-
29
-
-
33646215977
-
Clozapine Versus Risperidone in Psychosis
-
Presented at the Annual Meeting of the Society of Biological Psychiatry. Philadelphia, PA, May
-
Daniel DG, Goldberg T, Weinberger DR, et al. Clozapine Versus Risperidone in Psychosis. Presented at the Annual Meeting of the Society of Biological Psychiatry. Philadelphia, PA, May 1994.
-
(1994)
-
-
Daniel, D.G.1
Goldberg, T.2
Weinberger, D.R.3
-
31
-
-
0028850037
-
Discontinuing antipsychotic therapy - A practical guide
-
Keks NA, Copolov DL, Burrows GD. Discontinuing antipsychotic therapy - a practical guide. CNS Drugs 1995;4:351-356.
-
(1995)
CNS Drugs
, vol.4
, pp. 351-356
-
-
Keks, N.A.1
Copolov, D.L.2
Burrows, G.D.3
-
32
-
-
0018835477
-
Neuroleptic-induced supersensitivity psychosis: Clinical and pharmacological characteristics
-
Chouinard G, Jones BD. Neuroleptic-induced supersensitivity psychosis: clinical and pharmacological characteristics. Am J Psychiatry 1980;137:16-21.
-
(1980)
Am. J. Psychiatry
, vol.137
, pp. 16-21
-
-
Chouinard, G.1
Jones, B.D.2
-
33
-
-
0030023357
-
Clozapine withdrawal effects and receptor profiles of typical and atypical neuroleptics
-
Verghese C, DeLeon J, Nair C, Simpson GM. Clozapine withdrawal effects and receptor profiles of typical and atypical neuroleptics. Biol Psychiatry 1996;39:135-138.
-
(1996)
Biol. Psychiatry
, vol.39
, pp. 135-138
-
-
Verghese, C.1
DeLeon, J.2
Nair, C.3
Simpson, G.M.4
-
34
-
-
0020683905
-
Antidepressant withdrawal symptoms treated with anticholinergic agents
-
Dilsaver SC, Feinberg M, Greden JF. Antidepressant withdrawal symptoms treated with anticholinergic agents. Am J Psychiatry 1983;140:249-251.
-
(1983)
Am. J. Psychiatry
, vol.140
, pp. 249-251
-
-
Dilsaver, S.C.1
Feinberg, M.2
Greden, J.F.3
-
35
-
-
0012334897
-
Withdrawal symptoms after abrupt termination of imipramine
-
Shatan C. Withdrawal symptoms after abrupt termination of imipramine. Can Psychiatric Association J 1966;2:150-158.
-
(1966)
Can. Psychiatric Association J.
, vol.2
, pp. 150-158
-
-
Shatan, C.1
-
36
-
-
0013942220
-
Differential effects of abrupt versus gradual withdrawal of chlorpromazine in hospitalized chronic schizophrenic patients
-
Greenberg LM, Roth S. Differential effects of abrupt versus gradual withdrawal of chlorpromazine in hospitalized chronic schizophrenic patients. Am J Psychiatry 1966;123:221-226.
-
(1966)
Am. J. Psychiatry
, vol.123
, pp. 221-226
-
-
Greenberg, L.M.1
Roth, S.2
-
37
-
-
0012229479
-
Abrupt withdrawal of chlorpromazine and thioridazine from schizophrenic inpatients
-
Melnyk WT, Worthington AG, Laverty SG. Abrupt withdrawal of chlorpromazine and thioridazine from schizophrenic inpatients. Am J Psychiatry 1966;11:410-412.35.
-
(1966)
Am. J. Psychiatry
, vol.11
-
-
Melnyk, W.T.1
Worthington, A.G.2
Laverty, S.G.3
-
38
-
-
0024429166
-
Effect of typical and atypical antipsychotic drugs on 5-HT2 receptor density in rat cerebral cortex
-
Matsubara S, Meltzer HY. Effect of typical and atypical antipsychotic drugs on 5-HT2 receptor density in rat cerebral cortex. Life Sci 1989;45:1397-1406.
-
(1989)
Life Sci.
, vol.45
, pp. 1397-1406
-
-
Matsubara, S.1
Meltzer, H.Y.2
-
39
-
-
0027965174
-
Treatment of the serotonin syndrome with cyproheptadine
-
Lappin RI, Auchincloss EL. Treatment of the serotonin syndrome with cyproheptadine. N Engl J Med 1994;331:1021-1022.
-
(1994)
N. Engl. J. Med.
, vol.331
, pp. 1021-1022
-
-
Lappin, R.I.1
Auchincloss, E.L.2
|